The management decisions in the treatment of acute intermediate-risk pulmonary embolism (PE) can be complex. The choice of using anticoagulation alone vs. invoking advanced catheter-based thrombus removal therapies often requires consideration of many competing issues factors and involvement of a multidisciplinary PE response team (PERT). In this conversation, PERT pioneers at Massachusetts General Hospital describe their approach to intermediate-risk pulmonary embolism. More specifically: we discuss how to work up and think through various treatment strategies.
All authors: Vikas Aggarwal, MD, FSCAI, Ido Weinberg, MD (Director of Vascular Medicine at MGH), and Andrew Dicks, MD (Vascular Medicine Fellow)
Including recently published studies, coverage of late-breaking science, updates from clinical trials and registries, and complex case presentations.